Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor
- PMID: 1359534
- PMCID: PMC50280
- DOI: 10.1073/pnas.89.21.10075
Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor
Abstract
Activation of protein kinase C by phorbol esters is known to accelerate the processing and secretion of the beta/A4 amyloid protein precursor. We have now examined various first messengers that increase protein kinase C activity of target cells for their ability to affect beta/A4 amyloid protein precursor metabolism. Acetylcholine and interleukin 1, which are altered in Alzheimer disease, were shown to increase processing of the beta/A4 amyloid protein precursor via the secretory cleavage pathway. Cholinergic agonists stimulated secretion in human glioma and neuroblastoma cells as well as in PC12 cells transfected with the M1 receptor, while interleukin 1 stimulated secretion in human endothelial and glioma cells.
Similar articles
-
Intracellular production of beta A4 amyloid of Alzheimer's disease: modulation by phosphoramidon and lack of coupling to the secretion of the amyloid precursor protein.Biochemistry. 1995 Jun 27;34(25):8091-8. doi: 10.1021/bi00025a015. Biochemistry. 1995. PMID: 7794922
-
Phorbol esters but not the cholinergic agonists oxotremorine-M and carbachol increase release of the amyloid precursor protein in cultured rat cortical neurons.J Neurochem. 1996 Oct;67(4):1511-8. doi: 10.1046/j.1471-4159.1996.67041511.x. J Neurochem. 1996. PMID: 8858934
-
Protein phosphorylation inhibits production of Alzheimer amyloid beta/A4 peptide.Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):9195-8. doi: 10.1073/pnas.90.19.9195. Proc Natl Acad Sci U S A. 1993. PMID: 8415676 Free PMC article.
-
[Alzheimer disease. Role of beta A4 peptide and cerebral amyloid substance].Presse Med. 1994 May 14;23(18):848-54. Presse Med. 1994. PMID: 7937606 Review. French.
-
Amyloid precursor protein processing and bioenergetics.Brain Res Bull. 2017 Jul;133:71-79. doi: 10.1016/j.brainresbull.2016.08.009. Epub 2016 Aug 18. Brain Res Bull. 2017. PMID: 27545490 Free PMC article. Review.
Cited by
-
The association between late-life depression, mild cognitive impairment and dementia: is inflammation the missing link?Expert Rev Neurother. 2012 Nov;12(11):1339-50. doi: 10.1586/ern.12.127. Expert Rev Neurother. 2012. PMID: 23234395 Free PMC article. Review.
-
Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression.Br J Pharmacol. 2007 Aug;151(8):1272-9. doi: 10.1038/sj.bjp.0707337. Epub 2007 Jun 25. Br J Pharmacol. 2007. PMID: 17592514 Free PMC article.
-
Allosteric activators of muscarinic receptors as novel approaches for treatment of CNS disorders.Mol Biosyst. 2010 Aug;6(8):1345-54. doi: 10.1039/c002938f. Epub 2010 Jun 25. Mol Biosyst. 2010. PMID: 20582339 Free PMC article. Review.
-
A1 adenosine receptors accumulate in neurodegenerative structures in Alzheimer disease and mediate both amyloid precursor protein processing and tau phosphorylation and translocation.Brain Pathol. 2003 Oct;13(4):440-51. doi: 10.1111/j.1750-3639.2003.tb00475.x. Brain Pathol. 2003. PMID: 14655750 Free PMC article.
-
Inflammation as a central mechanism in Alzheimer's disease.Alzheimers Dement (N Y). 2018 Sep 6;4:575-590. doi: 10.1016/j.trci.2018.06.014. eCollection 2018. Alzheimers Dement (N Y). 2018. PMID: 30406177 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources